Inside the research
HealthStream, Inc.
HSTM Research profile · latest available data
Price overview
$29.10
▲ +0.23 (+0.8%)
| 52w hi | $29.77 |
|---|---|
| 52w lo | $19.79 |
| Vol | 196.40K |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.41
| Short | +0.36 |
|---|---|
| Medium | +0.52 |
| Long | +0.29 |
computed 2026-09-27
Key fundamentals
HealthStream, Inc.
Healthcare · Health Information Services
| Market cap | $890.34M |
|---|---|
| Enterprise value | $797.58M |
| Trailing P/E | 40.42x |
| Forward P/E | 32.88x |
| EV / EBITDA | 17.76x |
| P / S (ttm) | 2.77x |
| Profit margin | 6.6% |
| Return on equity | 6.0% |
| Revenue growth | +12.5% |
| Earnings growth | +28.4% |
| Debt / equity | 3.77 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.20 | |
| Sector | +0.08 | |
| Technical | +0.29 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company offers hStream, a technology platform; CredentialStream, provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure and other credentials, privileging, appointments by credentialing committees, enrollment, network, management, onboarding, and performance evaluations of providers; ShiftWizard; and Competency Suite, AI/ML-driven clinical competency development system. It also provides applications for performance appraisal, competency management, disclosure management, clinical competency, assessment, development, simulation-based education, clinical rotation and onboarding management, quality management, and industry training. The company's solutions help healthcare organizations in meeting their ongoing learning, clinical development, credentialing, and scheduling needs. It serves the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies, and nursing schools and students. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.
Risk Metrics
| Beta vs SPX | 0.49 |
|---|---|
| Corr SPX | 0.25 |
| Annual vol | 31.2% |
| Annual ret | +5.7% |
| Sharpe | 0.18 |
| Max DD | -41.6% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-03 | Earnings Release, Reg FD Disclosure… | read |
| 2026-07-29 | Other Material Event | read |
| 2026-05-29 | Shareholder Vote, Exhibits | read |
| 2026-05-08 | Officer / Director Change | read |
| 2026-05-04 | Earnings Release, Reg FD Disclosure… | read |
| 2026-03-13 | Material Agreement, Other Material Event… | read |
| 2026-02-23 | Earnings Release, Reg FD Disclosure… | read |
| 2025-12-15 | Other Material Event, Exhibits | read |
| 2025-12-09 | Other Material Event, Exhibits | read |
| 2025-11-12 | Other Material Event, Exhibits | read |
| 2025-11-03 | Earnings Release, Reg FD Disclosure… | read |
| 2025-10-09 | Other Material Event, Exhibits | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 9 |
| Top-5 share | 89.6% |
| HHI | 2,264 (moderate) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $27.36M | 1.00M |
| Norges Bank (Norway sovereign) | $16.13M | 591.90K |
| Renaissance Technologies | $11.53M | 423.00K |
| AQR Capital Management | $6.55M | 240.23K |
| Fidelity / FMR LLC | $4.55M | 166.81K |
| Capital Research / Capital World | $4.09M | 150.12K |
| Millennium Management | $3.31M | 121.34K |
| Citadel Advisors | $282.94K | 10.38K |
| T. Rowe Price Group | $895 | 32.84K |
As of 2026-06-30
SEC Filings
The Long Run
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $304.06M | +9.8% | |
| Operating income | $21.29M | +10.7% | |
| Net income | $18.34M | +7.2% | |
| Cash from ops | $63.32M | +12.4% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $28.79 | $29.31 | $28.56 | $29.10 | 196.40K |
| Sep 24 | $28.76 | $28.99 | $28.60 | $28.87 | 144.70K |
| Sep 23 | $29.01 | $29.11 | $28.62 | $28.76 | 143.60K |
| Sep 22 | $29.34 | $29.41 | $28.94 | $29.01 | 128.20K |
| Sep 21 | $29.39 | $29.72 | $28.79 | $29.08 | 176.40K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →